# A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

> **NCT02223884** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 30 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** docetaxel 35mg/m2
- **DRUG:** Carboplatin AUC3

## Key facts

- **NCT ID:** NCT02223884
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02223884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02223884, "A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02223884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*